Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,tetrahydrate

CAS: 934714-36-0

Ref. 3D-JMB71436

Produktinformation

• Name: Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,tetrahydrate

Beschreibung

Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,tetrahydrate is a prodrug of strontium that is hydrolyzed by esomeprazole and omeprazole to release the active form. Strontium has been shown to be effective in treatment of bowel disease. Strontium inhibits the production of prostaglandins and leukotrienes, leading to decreased inflammation in the gastrointestinal tract. It also has a therapeutic effect on reflux disease. Strontium can cause drug interactions with other drugs metabolized by cytochrome P450 enzymes (e.g., esomeprazole) or that inhibit gastric acid secretion (e.g., omeprazole).

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 848.5 g/mol
• Formel: C₃₄H₄₄N₆O₁₀S₂Sr
• Reinheit: Min. 95%